Multicenter Study of Fulminant Type 1 Diabetes in China

Recruiting Observational Study
Diabetes Mellitus, Type 1
Healthy Volunteers Welcome You do not need to have the condition being studied to take part. No Study Drug Researchers observe your health over time — no experimental treatment is given.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Sex
Any
Study type
Observational
Participants needed
240 (estimated)
Sponsor
Second Xiangya Hospital of Central South University · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial

This study took FT1D(fulminant type 1 diabetes) as the research object, collected the cases of FT1D patients, and described the clinical characteristics of this type of disease. The HLA susceptibility genes of FT1D were identified by PCR and other techniques, taking age-sex-matched healthy subjects as controls and HLA genes as the research entry point.

Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
patients with fulminant 1 diabetes Inclusion Criteria: 1\) diabetic ketosis or ketoacidosis occurred soon after the onset of hyperglycemic symptoms; 2) patient presented with plasma glucose ≥16.0 mmol/L and HbA1c \<8.7% at the first visit; and 3) patient had urinary C-peptide excretion \<10 µg/day…
Contacts

zhiguang zhou, MD

+8673185292154

zhouzhiguang@csu.edu.cn

CONTACT

shuoming luo, MD

shuomingluo@@csu.edu.cn

CONTACT